Tuesday, December 18, 2012

• Cellular Dynamics to develop, sell products for GE Healthcareat bizjournals.com (Tue, Dec 18)
• Has Pharmacyclics Become the Perfect Stock?at Motley Fool (Tue, Dec 18)
• A Geron Update: Imetelstat Data, Restructuring, And The Road Aheadat Seeking Alpha (Tue, Dec 18)
• Stem Cell Technology To Revolutionize The Skin Care Industry?at Seeking Alpha (Tue, Dec 18)

Sunday, December 16, 2012

• Has Geron Become the Perfect Stock?at Motley Fool (Sun, Dec 16)

Wednesday, December 12, 2012

• 3 Hematology Successes Biotech Investors Need to Knowat Motley Fool (Wed, Dec 12)
• Gilead adds to cancer franchise with planned $510M acquisitionat bizjournals.com (Wed, Dec 12)
• 5 Stocks To Watch In Biotechat Seeking Alpha (Wed, Dec 12)

Monday, December 10, 2012

• Is Geron's Latest Strategy Good News for Investors?at Motley Fool (Mon, Dec 10)
• Nexen, Priceline, AIG are big market moversAP (Mon, Dec 10)
• Geron rises on imetelstat blood disorder studyAP (Mon, Dec 10)
• This Week in Biotechat Motley Fool (Mon, Dec 10)
• The Dow's Response to These 3 Stocks: Get a Job!at Motley Fool (Mon, Dec 10)

Friday, December 7, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Dec 7)
• Geron ends technology licensing deal, will get $2.5 millionat bizjournals.com (Fri, Dec 7)
• GERON CORP Files SEC form 8-K, Other EventsEDGAR Online (Fri, Dec 7)

Thursday, December 6, 2012

• The Worst of 2012: BioTimeat Motley Fool (Thu, Dec 6)
• Outgoing Geron CFO lands $500K severance, bonusat bizjournals.com (Thu, Dec 6)
• Geron Scraps GRN1005, Cuts JobsZacks (Thu, Dec 6)
• GERON CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Costs Associated with Exit or DisposalEDGAR Online (Thu, Dec 6)
• More Bad News for Geron?at Motley Fool (Thu, Dec 6)
• Report recommends changes to California stem cell agency's board, goalsat bizjournals.com (Thu, Dec 6)

Tuesday, December 4, 2012

• Geron Plunge Doesn't Scare the Bullsat Minyanville (Tue, Dec 4)
• This Biotech Is a Train Wreckat Motley Fool (Tue, Dec 4)
• Geron skids after ending drug study, cutting jobsAP (Tue, Dec 4)

Add GERN News to My Yahoo!